Evidence map›Paper›PMID 36424560›Full record

ArticleBMC musculoskeletal disorders2022

Internal Hemipelvectomy for primary bone sarcomas using intraoperative patient specific instruments- the next step in limb salvage concept.

Amit Benady, Yair Gortzak, Summer Sofer, Yuval Ran, Netta Rumack, Avital Elias, Ben Efrima, Eran Golden, Ortal Segal, Omri Merose and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Surgical management of pelvic tumors through hemipelvectomyRevista medica del Instituto Mexicano del Seguro Social · 2024
    Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Amit BenadyLevin Center of Surgical Innovation and 3D Printing, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. amitbe@tlvmc.gov.il.
Yair GortzakSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Summer SoferLevin Center of Surgical Innovation and 3D Printing, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Yuval RanThe Military Track of Medicine, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Netta RumackSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Avital EliasSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ben EfrimaSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eran GoldenLevin Center of Surgical Innovation and 3D Printing, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Ortal SegalSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Omri MeroseSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Amir SternheimSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Solomon DadiaLevin Center of Surgical Innovation and 3D Printing, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Tel Aviv Sourasky Medical Center · ILTel Aviv University · ILHebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring pelvic Sarcoma resections, Surgeons often struggle to obtain negative margins while minimizing collateral damage and maintaining limb function. These complications are usually due to the complex anatomy of the pelvis. Here we present an accurate 3D surgical approach, including pre-operative printing of models and intraoperative patient-specific instruments (PSIs) for optimizing pelvic sarcoma resections.

methodsThis single-center retrospective study (N = 11) presents surgical, functional, and oncological outcomes of patients (average age 14.6 +/- 7.6 years, 4 males) who underwent pelvic sarcoma resections using a 3D surgical approach between 2016 and 2021. All patients were followed up for at least 24 months (mean = 38.9 +/- 30.1 months).

resultsOur results show promising surgical, oncological, and functional outcomes. Using a 3D approach, 90.9% had negative margins, and 63.6% did not require reconstruction surgery. The average estimated blood loss was 895.45 ± 540.12 cc, and the average surgery time was 3:38 ± 0.05 hours. Our results revealed no long-term complications. Three patients suffered from short-term complications of superficial wound infections. At 24 month follow up 72.7% of patients displayed no evidence of disease. The average Musculoskeletal Tumor Society (MSTS) score at 12 months was 22.81.

conclusion3D technology enables improved accuracy in tumor resections, allowing for less invasive procedures and tailored reconstruction surgeries, potentially leading to better outcomes in function and morbidity. We believe that this approach will enhance treatments and ease prognosis for patients diagnosed with pelvic sarcoma and will become the standard of care in the future.

Indexed as

Bone NeoplasmsHemipelvectomyOsteosarcomaSarcomaSoft Tissue NeoplasmsAdolescentAdultChildHumansLimb SalvageMaleMargins of ExcisionRetrospective StudiesTreatment OutcomeYoung Adult3D pre-operative planningAnatomical modelsInternal hemipelvectomyPatient specific instruments (PSI)Pelvic bone tumors

Identifiers

PMID36424560
PMCPMC9685900
OpenAlexW4309890108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.